Early cardiotoxicity after adjuvant concomitant treatment with radiotherapy and trastuzumab in patients with breast cancer
Tanja Marinko, Simona Borstnar, Rok Blagus, Jure Dolenc, Cvetka Bilban-Jakopin
Advancing HER2-low breast cancer management: enhancing diagnosis and treatment strategies
Simona Borstnar, Ivana Bozovic-Spasojevic, Ana Cvetanovic, Natalija Dedic Plavetic, Assia Konsoulova, Erika Matos, Lazar Popovic, Savelina Popovska, Snjezana Tomic, Eduard Vrdoljak
Symptoms of Anxiety and Depression Among Slovenian Breast Cancer Survivors Post-Treatment During the COVID-19 Pandemic: A Cross-Sectional Study
Špela MIROŠEVIČ, Judith PRINS, Nikola BEŠIĆ, Simona BORŠTNAR, Andreja Cirila ŠKUFCA SMRDEL, Vesna HOMAR, Marko POPOVIĆ, Zalika KLEMENC-KETIŠ
Triple negative breast cancer - prognostic factors and survival
Tanja Ovcaricek, Snjezana Frkovic, Erika Matos, Barbara Mozina, Simona Borstnar
Ribociclib plus letrozole in patients with hormone receptor-positive, HER2-negative advanced breast cancer with no prior endocrine therapy: subgroup safety analysis from the phase 3b CompLEEment-1 trial
Simona Borstnar, Marketa Palacova, Aleksandra Łacko, Constanta Timcheva, Einav Nili Gal-Yam, Konstantinos Papazisis, Juraj Beniak, Pavol Kudela, Gábor Rubovszky